SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $389,759,662 |
| Positions | 6 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | $131,681,580 | 1,186,000 |
| ARGENX SE | ARGX | SPONSORED ADR | $121,800,429 | 131,283 |
| REVOLUTION MEDICINES INC | RVMD | COM | $76,850,910 | 410,353 |
| CYTOKINETICS INC | CYTK | COM NEW | $40,465,250 | 475,000 |
| DISC MEDICINE INC | IRON | COM | $17,562,743 | 240,125 |
| TREVI THERAPEUTICS INC | TRVI | COM | $1,398,750 | 75,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.